Pandemic has brought new sense of awareness to respiratory diseases and clinops.
Susan Wood, PhD
Advertisement
President & CEO of VIDA Diagnostics
Articles by Susan Wood, PhD
Steps that investigators and sponsors can take to streamline trials and accelerate the time to market for lifesaving therapies.
Advertisement
Latest Updated Articles
- Streamlining the Complex Respiratory Clinical Trial Infrastructure
November 29th 2021
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion
2
ACT Brief: Multimodal AI Systems Architecture, Trust-Based Trial Recruitment, and Big Pharma AI Transformation
3
FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy
4
Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial
5